Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-07
2000-11-14
Seaman, D. Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546159, A61K 3147, C07D21538
Patent
active
061470899
ABSTRACT:
Cholesteryl ester transfer protein inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
REFERENCES:
patent: 5231101 (1993-07-01), Honda et al.
patent: 5231102 (1993-07-01), Baker et al.
patent: 5276168 (1994-01-01), Atwal
patent: 5288725 (1994-02-01), Witherup et al.
patent: 5401848 (1995-03-01), Atwal
Gordon DJ, et al., Circulation. 79(1):8-15, Jan. 1989 "High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies".
Chemical Abstracts vol. 116, 1992, 116:151569g.
Chemical Abstracts vol. 123, 1995, 123:55716b.
DeNinno Michael P.
Ruggeri Roger B.
Wester Ronald T.
Benson Gregg C.
Olson A. Dean
Pfizer Inc.
Richardson Peter C.
Seaman D. Margaret
LandOfFree
Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Annulated 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2065751